Alphabiomics Ltd
11232306
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/03/2025
micro entity
Next accounts due
31/12/2026
Confirmation statement
Last: 04/03/2026
Due 18/03/2027
Industry
Officers
director · Since 05/03/2018
SCIENTIFIC RESEARCH
BRITISH · UNITED KINGDOM · Age 59
Persons with Significant Control
Dr Robert Anthony Williamson
British,American · England · Age 59
Altair Court, Flat 20, London, N1 3HA
Notified 05/03/2018
Marcus Rauch
German · United Kingdom · Age 54
Altair Court, Flat 20, London, N1 3HA
Notified 05/03/2018
Dr Angelique Van 'T Wout
Dutch · Netherlands · Age 57
30, Escudolaan, Amsterdam, 1060 ST
Notified 29/07/2018
CompanyRankvs 3242+ SIC 72110 peers33
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
-£4k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£5k
Working capital
Current Assets
£13k
Current Liabilities
£18k
Fixed Assets
£1k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 0.73 | — |
| 2024 | 2.43 | — |
| 2023 | 1.00 | — |
| 2022 | 1.00 | — |
| 2021 | 1.00 | — |
| 2020 | 0.79 | -£88k |
| 2019 | Infinity | — |
Derived from filed accounts. Not audited figures.